Association of diminished expression of RASSF1A with promoter methylation in primary gastric cancer from patients of central China
- PMID: 17608924
- PMCID: PMC1925110
- DOI: 10.1186/1471-2407-7-120
Association of diminished expression of RASSF1A with promoter methylation in primary gastric cancer from patients of central China
Abstract
Background: Although methylation-mediated inactivation of expression of RASSF1A, a candidate tumor suppressor gene, has been observed in several human cancers, the data concerning alteration of RASSF1A expression and methylation in Chinese primary gastric cancer are scarce. Moreover, direct evidence showing the association between protein expression of RASSF1A and primary human cancers is lacking. The aim of this study was to investigate RASSF1A expression in tissue of primary gastric cancer (GC) at mRNA and protein levels, and to establish the possible relationship between DNA methylation status and protein expression of RASSF1A in Chinese.
Methods: Fifty-four patients with primary gastric cancers were included in the study of RASSF1A mRNA expression and methylation status between the cancer tissue and the corresponding adjacent normal tissue. 20 out of 54 patients were included for study of RASSF1A protein expression. The expression of RASSF1A at mRNA and protein levels was determined by RT-PCR and Western-blotting, respectively. The RASSF1A promoter methylation was detected by methylation-specific PCR.
Results: RASSF1A mRNA and protein expressions in GC were reduced significantly with comparison to the corresponding normal tissues (OD value: 0.2589 +/- 0.2407 vs 0.5448 +/- 0.2971, P < 0.0001; 0.1874 +/- 0.0737 vs 0.6654 +/- 0.2201, P < 0.0001, respectively). Methylation frequency of RASSF1A in primary GC is higher than that in the corresponding normal tissues (66.7% vs. 14.8%, P < 0.0001). Furthermore, RASSF1A mRNA expression in methylation group of GC was further reduced when compared to the unmethylation group of GC (0.1384 +/- 0.1142 vs. 0.5018 +/- 0.2463, P < 0.0001).
Conclusion: Expression of RASSF1A was reduced in tissue of GC at mRNA and protein levels. Diminished expression of RASSF1A was associated with the promoter methylation.
Figures



Similar articles
-
Aberrant CpG island hypermethylation of RASSF1A in gastric cardia adenocarcinoma.Cancer Invest. 2009 May;27(4):459-65. doi: 10.1080/07357900802620828. Cancer Invest. 2009. PMID: 19160099
-
[The influence of promoter methylation of RASSF1A on RASSF1A mRNA and protein expression in gastric cancer tissues].Zhonghua Nei Ke Za Zhi. 2006 Dec;45(12):1008-12. Zhonghua Nei Ke Za Zhi. 2006. PMID: 17327001 Chinese.
-
Polymorphism of A133S and promoter hypermethylation in Ras association domain family 1A gene (RASSF1A) is associated with risk of esophageal and gastric cardia cancers in Chinese population from high incidence area in northern China.BMC Cancer. 2013 May 25;13:259. doi: 10.1186/1471-2407-13-259. BMC Cancer. 2013. PMID: 23705663 Free PMC article.
-
Gene methylation in gastric cancer.Clin Chim Acta. 2013 Sep 23;424:53-65. doi: 10.1016/j.cca.2013.05.002. Epub 2013 May 10. Clin Chim Acta. 2013. PMID: 23669186 Review.
-
Association between RASSF1A promoter methylation and prostate cancer: a systematic review and meta-analysis.PLoS One. 2013 Sep 20;8(9):e75283. doi: 10.1371/journal.pone.0075283. eCollection 2013. PLoS One. 2013. PMID: 24073258 Free PMC article.
Cited by
-
Detection of RASSF1A promoter hypermethylation in serum from gastric and colorectal adenocarcinoma patients.World J Gastroenterol. 2008 May 21;14(19):3074-80. doi: 10.3748/wjg.14.3074. World J Gastroenterol. 2008. PMID: 18494062 Free PMC article.
-
Combined Detection of Plasma ZIC1, HOXD10 and RUNX3 Methylation is a Promising Strategy for Early Detection of Gastric Cancer and Precancerous Lesions.J Cancer. 2017 Apr 8;8(6):1038-1044. doi: 10.7150/jca.18169. eCollection 2017. J Cancer. 2017. PMID: 28529617 Free PMC article.
-
Methylation Analysis of P16, RASSF1A, RPRM, and RUNX3 in Circulating Cell-Free DNA for Detection of Gastric Cancer: A Validation Study.Avicenna J Med Biotechnol. 2020 Apr-Jun;12(2):99-106. Avicenna J Med Biotechnol. 2020. PMID: 32431794 Free PMC article.
-
Genomic and epigenetic profiles of gastric cancer: potential diagnostic and therapeutic applications.Surg Today. 2011 Jan;41(1):24-38. doi: 10.1007/s00595-010-4370-5. Epub 2010 Dec 30. Surg Today. 2011. PMID: 21191688 Review.
-
Clinicopathological significance of RASSF1A reduced expression and hypermethylation in hepatocellular carcinoma.Hepatol Int. 2010 Jan 29;4(1):423-32. doi: 10.1007/s12072-010-9164-8. Hepatol Int. 2010. PMID: 20305761 Free PMC article.
References
-
- Kok K, Naylor SL, Buys CH. Deletions of the short arm of chromosome 3 in solid tumors and the search for suppressor genes. Adv Cancer Res. 1997;71:27–92. - PubMed
-
- Byun DS, Lee MG, Chae KS, Ryu BG, Chi SG. Frequent epigenetic inactivation of RASSF1A by aberrant promoter hypermethylation in human gastric adenocarcinoma. Cancer Res. 2001;61:7034–7038. - PubMed
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Medical
Miscellaneous